发明名称 ANTI-CD38 ANTIBODIES AND FUSIONS TO ATTENUATED INTERFERON ALPHA-2B
摘要 <p>Antibodies that specifically bind to CD38, as well as constructs comprising such antibodies fused to attenuated interferon alpha-2B proteins are provided. Anti-CD38-attenuated interferon alpha-2b fusion constructs may be used to inhibit proliferation in cancerous cells that express both CD38 and the receptor for IFN-alpha2b, as well as to induce apoptosis in such cells. Inhibition of proliferation and induction of apoptosis in cancerous cells may serve as the basis for the treatment of the underlying cancer.</p>
申请公布号 CA2909952(A1) 申请公布日期 2014.11.06
申请号 CA20132909952 申请日期 2013.04.29
申请人 TEVA PHARMACEUTICALS AUSTRALIA PTY LTD. 发明人 CLARKE, ADAM W.;POLLARD, MATTHEW;DOYLE, ANTHONY G.;BEHRENS, COLLETTE;YAMAGISHI, TETSUO;WILSON, DAVID S., JR.;POGUE, SARAH L.;TAURA, TETSUYA
分类号 C07K16/28;C07K14/00 主分类号 C07K16/28
代理机构 代理人
主权项
地址